Category: Becton Dickinson & Co.
Spinal devices maker Vexim appoints as its director of marketing Sandrine Carle, a veteran of spinal operations at medtech giant Medtronic.
French spinal devices maker Vexim (EPA:ALVXM) this month welcome Medtronic (NYSE:MDT) veteran Sandrine Carle as its director of marketing.
Philips names Brent Shafer its new CEO for North America, promoting him from chief of the home healthcare solutions group.
Technology giant Philips (NYSE:PHG) named a new North America CEO this week, promoting home health solutions chief Brent Shafer to replace Greg Sebasky, who retired this week.
First-quarter earnings for Becton, Dickinson & Co. top expectations, prompting the medtech company to boost the bottom end of its outlook for fiscal 2014.
Becton Dickinson & Co. (NYSE:BDX) beat the consensus forecast for its fiscal 1st-quarter earnings and boosted the bottom end of its outlook for the rest of fiscal 2014, sending share up slightly today.
Becton, Dickinson & Co. pays $40 million to acquire optoelectronics diagnostics device maker Alverix.
Becton, Dickinson & Co. says Brazil's Secretariat of Foreign Trade is probing whether it dumped vacuum tubes onto the Brazilian market for less than their price in the U.S.
Becton Dickinson & Co. (NYSE:BDX) said a Brazilian agency today began an anti-dumping probe that's looking into sales in Brazil of its vacuum tubes used to collect blood.
Third-quarter losses mount for Retractable Technologies as sales decline 3%.
Retractable Technologies (NYSE:RVP) continued its descent into the red as 3rd-quarter losses mounted amid declining sales.
Becton Dickinson hands out promotions as it releases mixed Q4 earnings that best analysts' projections
Becton Dickinson & Co. (NYSE:BDX) beat Wall Street's estimates for its 4th quarter of 2013 and handed out a couple of promotions during the company's quarterly conference call with investors.